Breast 3DUS ABUS System Comparison
Comparing the Efficacy of 3D Ultrasound Imaging of Breast Pathology Between a Custom ITA Device and Invenia™ ABUS System by GE Medical
Western University, Canada
30 participants
Aug 18, 2024
INTERVENTIONAL
Conditions
Summary
This comparative study will recruit 30 females who are scheduled for mammography and ultrasound assessment. The clinical 2D ultrasound is performed routinely, and the research portion of this study will add a few extra 3-D ultrasound images during the procedure. The ultrasound imaging laboratory under the direction of Dr. Aaron Fenster has developed a customized device designed to acquire 3D ultrasound of the breast using a commercial ultrasound machine. The purpose is to see how well 3-dimensional ultrasound acquire from that device is able to visualize tumours and other key features in comparison to the clinical system InveniaTM developed by GE Medical.
Eligibility
Inclusion Criteria4
- Adult Patients who are scheduled for screening ABUS
- Adults Patients who are scheduled for short term follow-up with ABUS.
- Must be at least 18 years of age or older.
- Must be proficient in English (reading/writing).
Exclusion Criteria3
- Patients with breast implants.
- Patients with contraindication for ABUS.
- Patients who cannot tolerate ABUS.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A custom device will be used with a clinical ultrasound machine to acquire ultrasound images of the breast.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06118996